Wainua (eplontersen)

Approved for WAINUA is indicated for the treatment of the polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults.. Eplontersen is an antisense oligonucleotide-GalNAc conjugate that causes degradation of mutant and wild-type TTR mRNA through binding to the TTR mRNA, which results in a reduction of serum TTR… Side effects, costs, interactions, manufacturer, and generic…

Loading full data from Know Your Drugs Institute…